Erfelijk prostaatcarcinoom

Nederlands Tijdschrift voor Geneeskunde

Volumn 140, Issue 20, 1996, Pages 1068-1072

  Kiemeney, L A L M ^a,b   Witjes, J A ^a,c   Hendrikx, A J M ^a,d   Kil, P J M ^a,e   Vasen, H F A ^a  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c CATHARINA HOSPITAL   (Netherlands)

^d CPRLab   (Netherlands)

^e Stichting Opsporing Erfelijke Tumoren   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GENETICS; CANCER RISK; HUMAN; MALE; PROSTATE CARCINOMA; REVIEW; ADULT; AGE; AGED; CHROMOSOME 8; CLUSTER ANALYSIS; GENETICS; HETEROZYGOTE DETECTION; MIDDLE AGED; NETHERLANDS; PEDIGREE; PROSTATE TUMOR; RISK FACTOR; TWINS;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHROMOSOMES, HUMAN, PAIR 8; CLUSTER ANALYSIS; DISEASES IN TWINS; HETEROZYGOTE DETECTION; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PEDIGREE; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 0030592059     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Morganti G, Gianferrari L, Cresseri A, Arrigoni G, Lovali G. Recherches clinicostatistiques et génétiques sur les néoplasies de la prostate. Acta Genet Stat Med 1956;6:304-5.
2. Woolf CM. An investigation of the familial aspects of carcinoma of the prostate. Cancer 1960;13:739-44.
3. Krain LS. Some epidemiologic variables in prostatic carcinoma in California. Prev Med 1974;3:154-9.
4. Schuman LM, Mandel J, Blackard C, Bauer H, Scarlett J, McHugh R. Epidemiologic study of prostatic cancer: preliminary report. Cancer Treat Rep 1977;61:181-6.
5. Cannon L, Bishop DT, Skolnick M, Hunt S, Lyon JL, Smart CR. Genetic epidemiology of prostate cancer in the Utah Mormon genealogy. Cancer Surv 1982;1:48-69.
6. Meikle AW, Smith JA, West DW. Familial factors affecting prostatic cancer risk and plasma sex-steroid levels. Prostate 1985;6:121-8.
7. Ghadirian P, Cadotte M, Lacroix A, Perret C. Family aggregation of cancer of the prostate in Québec: the tip of the iceberg. Prostate 1991;19:43-52.
8. Spitz MR, Currier RD, Fueger JJ, Babaian RJ, Newell GR. Familial patterns of prostate cancer: a case-control analysis. J Urol 1991; 146:1305-7.
9. Steinberg GD, Carter BS, Beaty TH, Childs B. Walsh PC. Family history and the risk of prostate cancer. Prostate 1990;17:337-47.
10. Whittemore AS, Wu AH, Kolonel LN, John EM, Gallagher RP, Howe GR, et al. Family history and prostate cancer risk in black, white and Asian men in the United States and Canada. Am J Epidemiol 1995;141:732-40.
11. Carter BS, Beaty TH, Steinberg GD, Childs B, Walsh PC. Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci USA 1992;89:3367-71.
12. Gronberg H, Damber L, Damber JE. Studies of genetic factors in prostate cancer in a twin population. J Urol 1994;152:1484-9.
13. Braun MM, Partin AW, Caporaso N, Page WF, Walsh PC. Prostate cancer concordance rates among World War II veteran twins suggest hereditary influences. J Urol 1995;153 Suppl:504A.
14. Carter BS, Bova GS, Beaty TH, Steinberg GD, Childs B, Isaacs WB, et al. Hereditary prostate cancer: epidemiologic and clinical features. J Urol 1993;150:797-802.
15. Bastacky SI, Wojno KJ, Walsh PC, Carmichael MJ, Epstein JI. Pathological features of hereditary prostate cancer. J Urol 1995;153:987-92.
16. Bova GS, Isaacs SD, Partin AW, Isaacs WB, Walsh PC, Biological aggressiveness of hereditary prostate cancer (HPC): long term evaluation following radical prostatectomy (RRP). J Urol 1995;153 Suppl:505A.
17. Isaacs WB, Bova GS, Morton RA, Bussemakers MJ, Brooks JD, Ewing CM. Molecular biology of prostate cancer. Semin Oncol 1994;21:514-21.
18. Umbas R, Isaacs WB, Bringuier PP, Schaafsma HE, Karthaus HF, Oosterhof GON, et al. Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res 1994;54:3929-33.
19. McPherson JD, Morton RA, Ewing CM, Wasmuth JJ, Overhauser J, Nagafuchi A, et al. Assignment of the human alpha-catenin gene (CTNNAI) to chromosome 5q21-q22. Genomics 1994;19: 188-90.
20. Isaacs SD, Kiemeney LALM, Baffoe-Bonnie A, Beaty TH, Walsh PC. Risk of cancer in relatives of prostate cancer probands. J Natl Cancer Inst 1995;87:991-6.
21. Visser O, Coebergh JWW, Scheuten LJ, redacteuren. Incidence of cancer in the Netherlands, 1991. Utrecht, Vereniging van Integrale Kankercentra, 1994.
22. Schouten LJ, Straatman H, Kiemeney LALM, Verbeek ALM. Cancer incidence: life table risk versus cumulative risk. J Epidemiol Community Health 1994;48:596-600.
23. Wingo PA, Tong T, Bolden S. Cancer statistics, 1995. CA Cancer J Clin 1995;45:8-30.
24. Feuer E, Ming Wun L, Timmel M, Torbet K. Probability of developing cancer. Bethesda, Md.: National Cancer Institute, 1993.
25. Coleman MP, Esteve J, Damiecki P, Arslan A, Renard H, editors. Trends in cancer incidence and mortality. IARC Sci Publ 1993;121: 1-806.
26. Cox DR. Regression models and life tables. J R Stat Soc 1972;34:187-220.
27. Gezondheidsraad. Commissie screening erfelijke en aangeboren aandoeningen. Genetische screening. Publikatienr 1994/22. Den Haag: Gezondheidsraad, 1994.
28. Waterbor JW, Bueschen AJ. Prostate cancer screening. Cancer Causes Control 1995;6:207-74.
29. McWhorter WP, Hernandez AD, Meikle AW, Terrcros DA, Smith jr JA, Skolnick MH, et al. A screening study of prostate cancer in high risk families. J Urol 1992;148:826-8.